Physician profile
Kiron Thomas
NPI 1548456155
$2,534.41
in general payments reported to CMS, 2019-2025
17 companies · $280 in 2025
The $280 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $84.45 · 2021: $93.00 · 2022: $97.51 · 2023: $1,421 · 2024: $373 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,127 · Food and Beverage: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,126.75 |
| Food and Beverage | $947.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $1,415.82 | 2019-2023 | Web Aneurysm Embolization System |
| Stryker Corporation | $306.55 | 2024-2025 | Surpass Evolve, Trevo, Target |
| Medtronic USA, INC. | $156.71 | 2019 | |
| Biogen, INC. | $110.58 | 2022-2023 | Vumerity, Tysabri |
| Medtronic Vascular, INC. | $84.45 | 2020 | |
| Ucb, INC. | $80.02 | 2024-2025 | Rystiggo |
| Merz Pharmaceuticals, LLC | $61.09 | 2024-2025 | Xeomin, Ampyra, Inbrija |
| Abbvie INC. | $59.93 | 2023-2025 | Qulipta |
| Lundbeck LLC | $54.49 | 2024-2025 | Vyepti |
| Neurelis, INC. | $42.95 | 2023-2025 | Valtoco |
| Viz.Ai, INC. | $29.66 | 2022 | |
| Tanabe Pharma America, INC. | $26.05 | 2024 | |
| Octapharma USA, INC. | $25.30 | 2025 | Panzyga |
| Eisai INC. | $24.85 | 2024 | |
| Genentech USA, INC. | $24.84 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $15.82 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Acist Medical Systems, INC. | $15.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiron Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.